Contraception in Women With Sickle Cell Disease
NCT02594462
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Interventions
DRUG:
etonogestrel-releasing implant contraceptive
Sponsor
University of Sao Paulo
Collaborators
[object Object]